BACKGROUND: Transforming growth factor-beta (TGF-beta), a profibrotic cytokine involved in many scarring processes, has to be activated extracellularly before it can bind to its receptors. Thrombospondin 1 (TSP1), a multifunctional matricellular glycoprotein, has been identified as an activator of TGF-beta in in vitro systems and during mouse postnatal development in vivo. TSP1 is expressed de novo in many inflammatory disease processes, including glomerular disease. METHODS: In this study we investigated whether peptides specifically interfering with the activation process of TGF-beta by TSP1 may be able to block activation of TGF-beta in an in vivo model of mesangial proliferative glomerulonephritis. RESULTS: Continuous intravenous infusion of blocking peptide by minipumps significantly reduced expression of active TGF-beta in glomeruli on day 7 of disease as indicated by immunohistochemistry, bioassay, and activation of the TGF-beta signal transduction pathway, while total TGF-beta expression was unchanged. Inhibition of glomerular TGF-beta activation was accompanied by a decrease of glomerular extracellular matrix accumulation and proteinuria, but was without effect on mesangial cell proliferation or influx of monocytes/macrophages. CONCLUSION: TSP1 is a major endogenous activator of TGF-beta in experimental inflammatory glomerular disease. Drugs interfering with the activation of TGF-beta by locally produced TSP1 may be considered as a future specific treatment of scarring kidney disease.
BACKGROUND: Transforming growth factor-beta (TGF-beta), a profibrotic cytokine involved in many scarring processes, has to be activated extracellularly before it can bind to its receptors. Thrombospondin 1 (TSP1), a multifunctional matricellular glycoprotein, has been identified as an activator of TGF-beta in in vitro systems and during mouse postnatal development in vivo. TSP1 is expressed de novo in many inflammatory disease processes, including glomerular disease. METHODS: In this study we investigated whether peptides specifically interfering with the activation process of TGF-beta by TSP1 may be able to block activation of TGF-beta in an in vivo model of mesangial proliferative glomerulonephritis. RESULTS: Continuous intravenous infusion of blocking peptide by minipumps significantly reduced expression of active TGF-beta in glomeruli on day 7 of disease as indicated by immunohistochemistry, bioassay, and activation of the TGF-beta signal transduction pathway, while total TGF-beta expression was unchanged. Inhibition of glomerular TGF-beta activation was accompanied by a decrease of glomerular extracellular matrix accumulation and proteinuria, but was without effect on mesangial cell proliferation or influx of monocytes/macrophages. CONCLUSION:TSP1 is a major endogenous activator of TGF-beta in experimental inflammatory glomerular disease. Drugs interfering with the activation of TGF-beta by locally produced TSP1 may be considered as a future specific treatment of scarring kidney disease.
Authors: Chan Woo Kim; Anastassia Pokutta-Paskaleva; Sandeep Kumar; Lucas H Timmins; Andrew D Morris; Dong-Won Kang; Sidd Dalal; Tatiana Chadid; Katie M Kuo; Julia Raykin; Haiyan Li; Hiromi Yanagisawa; Rudolph L Gleason; Hanjoong Jo; Luke P Brewster Journal: Circulation Date: 2017-08-04 Impact factor: 29.690
Authors: Casey W Shuptrine; Reham Ajina; Elana J Fertig; Sandra A Jablonski; H Kim Lyerly; Zachary C Hartman; Louis M Weiner Journal: Cancer Immunol Immunother Date: 2017-08-02 Impact factor: 6.968
Authors: Leslie Gewin; Nada Bulus; Glenda Mernaugh; Gilbert Moeckel; Raymond C Harris; Harold L Moses; Ambra Pozzi; Roy Zent Journal: J Am Soc Nephrol Date: 2010-06-24 Impact factor: 10.121
Authors: Natasha M Rogers; Mingyi Yao; Enrico M Novelli; Angus W Thomson; David D Roberts; Jeffrey S Isenberg Journal: Am J Physiol Renal Physiol Date: 2012-08-08
Authors: Bernd Hohenstein; Christoph Daniel; Birgit Hausknecht; Kirsten Boehmer; Regine Riess; Kerstin U Amann; Christian P M Hugo Journal: Nephrol Dial Transplant Date: 2008-07-30 Impact factor: 5.992